Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1940 1
1942 1
1946 1
1947 3
1949 2
1951 2
1952 2
1954 2
1956 3
1958 1
1960 2
1961 2
1962 3
1963 5
1964 1
1965 2
1967 1
1968 5
1969 4
1970 5
1971 12
1972 12
1973 8
1974 9
1975 8
1976 4
1977 7
1978 13
1979 12
1980 11
1981 11
1982 16
1983 12
1984 9
1985 13
1986 16
1987 24
1988 22
1989 19
1990 28
1991 29
1992 32
1993 31
1994 34
1995 50
1996 46
1997 19
1998 38
1999 38
2000 54
2001 34
2002 46
2003 51
2004 40
2005 44
2006 44
2007 60
2008 62
2009 90
2010 90
2011 82
2012 90
2013 90
2014 96
2015 102
2016 113
2017 120
2018 141
2019 113
2020 137
2021 169
2022 100
Text availability
Article attribute
Article type
Publication date

Search Results

2,373 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, Kaufman D, Ligueros-Saylan M, Howard M, Zhu R, Owen R, Wong K, Islam L, Bachert C. Gevaert P, et al. Among authors: howard m. J Allergy Clin Immunol. 2020 Sep;146(3):595-605. doi: 10.1016/j.jaci.2020.05.032. Epub 2020 Jun 7. J Allergy Clin Immunol. 2020. PMID: 32524991 Free article. Clinical Trial.
Rehabilitation to enable recovery from COVID-19: a rapid systematic review.
Goodwin VA, Allan L, Bethel A, Cowley A, Cross JL, Day J, Drummond A, Hall AJ, Howard M, Morley N, Thompson Coon J, Lamb SE. Goodwin VA, et al. Among authors: howard m. Physiotherapy. 2021 Jun;111:4-22. doi: 10.1016/j.physio.2021.01.007. Epub 2021 Feb 24. Physiotherapy. 2021. PMID: 33637294 Free PMC article.
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, Fisher GA, Villalobos V, Prohaska SS, Howard M, Beeram M, Chao MP, Agoram B, Chen JY, Huang J, Axt M, Liu J, Volkmer JP, Majeti R, Weissman IL, Takimoto CH, Supan D, Wakelee HA, Aoki R, Pegram MD, Padda SK. Sikic BI, et al. Among authors: howard m. J Clin Oncol. 2019 Apr 20;37(12):946-953. doi: 10.1200/JCO.18.02018. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811285 Free PMC article. Clinical Trial.
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.
Callaghan MU, Negrier C, Paz-Priel I, Chang T, Chebon S, Lehle M, Mahlangu J, Young G, Kruse-Jarres R, Mancuso ME, Niggli M, Howard M, Bienz NS, Shima M, Jiménez-Yuste V, Schmitt C, Asikanius E, Levy GG, Pipe SW, Oldenburg J. Callaghan MU, et al. Among authors: howard m. Blood. 2021 Apr 22;137(16):2231-2242. doi: 10.1182/blood.2020009217. Blood. 2021. PMID: 33512413 Free PMC article. Clinical Trial.
Temperature-dependent growth contributes to long-term cold sensing.
Zhao Y, Antoniou-Kourounioti RL, Calder G, Dean C, Howard M. Zhao Y, et al. Among authors: howard m. Nature. 2020 Jul;583(7818):825-829. doi: 10.1038/s41586-020-2485-4. Epub 2020 Jul 15. Nature. 2020. PMID: 32669706 Free PMC article.
Low immunogenicity of emicizumab in persons with haemophilia A.
Schmitt C, Emrich T, Chebon S, Fernandez E, Petry C, Yoneyama K, Kiialainen A, Howard M, Niggli M, Paz-Priel I, Chang T. Schmitt C, et al. Among authors: howard m. Haemophilia. 2021 Nov;27(6):984-992. doi: 10.1111/hae.14398. Epub 2021 Sep 4. Haemophilia. 2021. PMID: 34480814 Free PMC article.
2,373 results